Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$153.1M
Close$
$-8.40
202.6% downside
Current Fair Value
202.6% downsideOvervalued by 202.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $153.10 Million |
|---|---|
| Enterprise Value | $91.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.37 |
| Outstanding Shares | 17,106,000 |
Return
| Return on Equity | -208.95% |
|---|---|
| Return on Assets | -159.84% |
| Return on Invested Capital | -181.30% |
Valuation & Multiples
| P/E Ratio | -2.32 |
|---|---|
| PEG | 2.67 |
| Price to Sales | 4.1 |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | 2.53 |
| Enterprise Value to EBIT | -0.2 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
$15.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 13.0927▼ 419.48% |
|---|---|
| Total Calls | 65,800▼ 0.30% |
| Total Puts | 861,500▼ 24.49% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.59%▼ 2.12% |
|---|---|
| Total Invested | $194.63M▼ 1.86% |
| Investors Holding | 159▼ 9.00% |
ESG Score
No data